This is an archive article published on July 29, 2021

IPO Wrap: Glenmark Life Sciences IPO subscribed 44.17 times on final day led by non institutional investors, QIBs

Glenmark Life Sciences IPO subscription status: Glenmark Life Sciences IPO was subscribed 44.17 times on the final day of the offer.

Glenmark Life Sciences IPO will be available from July 27-29, 2021. (Representative image: Pixabay)

3 min readNew DelhiJul 30, 2021 09:45 AM IST First published on: Jul 29, 2021 at 05:35 PM IST

Glenmark Life Sciences IPO subscription status: The initial public offering (IPO) of Glenmark Life Sciences, a wholly-owned subsidiary of Glenmark Pharmaceuticals, which was launched earlier this week was met with a robust demand by the investors.

Glenmark Life Sciences IPO was subscribed 44.17 times on the final day, data available on the BSE showed. The Rs 1,513.6 crore offer received bids for over 66.32 crore (66,32,97,760) shares against the total issue size of 1.50 crore (1,50,18,279) shares, the data showed.

The shares which are to be allocated for the qualified institutional buyers (QIBs) got subscribed 36.97 times, while those of non institutional investors were subscribed a whopping 122.54 times and that of retail individual investors (RIIs) was subscribed 14.63 times, the BSE data showed.